1. Home
  2. PBH vs NVCR Comparison

PBH vs NVCR Comparison

Compare PBH & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prestige Consumer Healthcare Inc.

PBH

Prestige Consumer Healthcare Inc.

HOLD

Current Price

$46.84

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$14.46

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PBH
NVCR
Founded
1996
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.0B
IPO Year
2004
2015

Fundamental Metrics

Financial Performance
Metric
PBH
NVCR
Price
$46.84
$14.46
Analyst Decision
Buy
Buy
Analyst Count
3
6
Target Price
$75.33
$28.08
AVG Volume (30 Days)
621.9K
1.4M
Earning Date
05-08-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
21.79
EPS
3.91
N/A
Revenue
$975,777,000.00
$655,353,000.00
Revenue This Year
N/A
$7.72
Revenue Next Year
$4.31
$6.74
P/E Ratio
$12.03
N/A
Revenue Growth
36.77
8.28
52 Week Low
$42.62
$9.82
52 Week High
$85.29
$18.92

Technical Indicators

Market Signals
Indicator
PBH
NVCR
Relative Strength Index (RSI) 41.50 36.40
Support Level $44.51 $12.66
Resistance Level $49.51 $15.46
Average True Range (ATR) 1.77 1.04
MACD 0.28 -0.28
Stochastic Oscillator 40.29 5.54

Price Performance

Historical Comparison
PBH
NVCR

About PBH Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: